Selumetinib is currently FDA approved for children 2 years and older with symptomatic and inoperable plexiform neurofibromas.

"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...

Zejula with Zytiga and prednisone delayed cancer growth and symptoms in patients with castration-sensitive prostate cancer ...

Metformin was associated with significantly reduced knee pain among patients with overweight/obesity and knee osteoarthritis.

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

Karnataka has advised parents to keep symptomatic children home from school amid a rise in COVID-19 cases, urging strict ...